
For example, one study in healthy middle-aged volunteers showed that taking 80mg of curcumin a day for four weeks reduced markers of inflammation and oxidative stress. There are already some promising results from studies of curcumin in healthy people. While any meaningful clinical effects are far from proven, at least the trials have a scientific foundation. In 1937, a paper in the Lancet medical journal described successful case studies using curcumin in the treatment of inflamed gall bladders.Īround 150 curcumin studies are under way to investigate the effects of curcumin (alone or in combination with other drugs) on cancer, heart disease, diabetes and dementia. The purported medical effects of curcumin have a long history, going back at least to the 18th century.

It is one of more than 5,000 flavonoids, a group of plant-based compounds thought to contribute to the health benefits of fruit and vegetables. Swinburne University of Technology provides funding as a member of The Conversation AU.Ĭurcumin is the component of turmeric ( Curcuma longa) that gives the spice its bright yellow colour. Katherine Cox does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.


He has received funding from the Biotechnology and Biological Sciences Research Council (UK), the European Union Framework scheme, the Australian Research Council, the National Health and Medical Research Council, the British Psychological Society, Abbott Nutrition/CNLM Grand Challenge scheme (USA), Arla Foods (Denmark), the Australian Wine Research Institute, Bayer Healthcare (Switzerland), Cognis (Germany), Cyvex (USA), GlaxoSmithKline Nutrition (UK), Kemin Nutrition and Health (USA), Masterfoods (USA), Martek (USA), Naturex (France), Nestlé (Switzerland), Neurobrands (USA), Red Bull (Austria), Sanofi, Verdure Sciences and Wrigley (USA). PhD Candidate, Centre for Human Psychopharmacology, Swinburne University of TechnologyĪndrew Scholey consults to the food and supplement industry. Professor and Director of the Centre for Human Psychopharmacology, Swinburne University of Technology
